Pnc Financial Services Group, Inc. Vaxart, Inc. Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.6 - $1.41 $189 - $445	316 Added 300.95%	421 $0
Q2 2022 Aug 12, 2022	SELL	$2.7 - $5.28 $8,588 - $16,795	-3,181 Reduced 96.8%	105 $0
Q2 2021 Aug 06, 2021	BUY	$5.06 - $10.78 $531 - $1,131	105 Added 3.3%	3,286 $24,000
Q3 2020 Nov 06, 2020	SELL	$4.78 - $16.97 $6,070 - $21,551	-1,270 Reduced 28.53%	3,181 $21,000
Q2 2020 Aug 07, 2020	BUY	$1.68 - $8.85 $2,133 - $11,239	1,270 Added 39.92%	4,451 $39,000
Q1 2018 May 11, 2018	BUY	$4.95 - $9.02 $15,745 - $28,692	3,181 New	3,181 $0

108

37.9M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.